Rana R McKay, Theresa Gold, Jelani C Zarif, Ilkania M Chowdhury-Paulino, Adam Friedant, Travis Gerke, Marie Grant, Kelly Hawthorne, Elisabeth Heath, Franklin W Huang, Maria D Jackson, Brandon Mahal, Osarenren Ogbeide, Kellie Paich, Camille Ragin, Emily M Rencsok, Stacey Simmons, Clayton Yates, Jake Vinson, Philip W Kantoff, Daniel J George, Lorelei A Mucci
Prostate cancer disproportionately affects racial and ethnic minority populations. Reasons for disparate outcomes among minority patients are multifaceted and complex, involving factors at the patient, provider, and system levels. Although advancements in our understanding of disease biology have led to novel therapeutics for men with advanced prostate cancer, including the introduction of biomarker-driven therapeutics, pivotal translational studies and clinical trials are underrepresented by minority populations...
April 2021: JCO global oncology